NASDAQ:ABUS   Arbutus Biopharma Corporation
$3.60 arrea was heavy resistance, now it's strong support.
Touching trend line and Over sold
RSI tuning green, prepping for another run up.

Yahoo Finance says it's 26% under valued.

Looks like a decent entry point with a SL below $3.60
Heavy Resistance at $4.50 and could turn into a H+S

Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.